Incidence and Mortality Rates of Kidney, Breast, Prostate Cancers
When compared to breast and prostate cancer, kidney cancer has the highest mortality rate, despite having the lowest projected incidence. In the U.S. alone, roughly 25% of kidney cancer patients will lose their battle this year, as compared to 23% of breast cancer patients and 12% of prostate cancer patients.
Mortality Ratios for Breast, Prostate, Melanoma & Kidney Cancers *2009 Stats from American Cancer Society
All Cancers 38%
Yet, kidney cancer receives approximately 1/17 of the amount of funding as breast cancer and only 1/10 the amount as prostate cancer.
Federal Funding for Breast, Prostate, Melanoma and Kidney Cancers *2008 Stats from www.cancer.gov (National Cancer Institute)
Breast 572.6 million
Prostate 285.4 million
Melanoma 110.8 million
Kidney 43.4 million
While melanoma has a slightly higher incidence rate than kidney cancer (59,940 v. 51,190) and lower mortality rate (14% v. 25%), the National Cancer Institute provides over three times as much funding for melanoma research than it does for kidney cancer research ($97,199,000 v. $31,055,000).